Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Rancho Cantera
WARNING LETTER
•Rancho Cantera•November 26, 2012

FDA WARNING_LETTER - Rancho Cantera - November 26, 2012

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Rancho Cantera
Record Details

On November 19 and 26, 2012, the FDA investigated Rancho Cantera, LLC, a dairy farm in Kent, Illinois, and found violations of the Federal Food, Drug, and Cosmetic Act. A Holstein dairy cow sold for slaughter on June 18, 2012, was found to have a violative residue of 0.11 ppm of ampicillin in its kidney, exceeding the 0.05 ppm tolerance level for penicillin in cattle, rendering the food adulterated under Section 402(a)(2)(C)(ii) of the FD&C Act.

The investigation also revealed insanitary conditions where medicated animals with harmful drug residues could enter the food supply, specifically due to the failure to maintain complete treatment records and a drug inventory system. Furthermore, the new animal drug Polyflex Ampicillin for injectable Suspension, NADA 55-030, was adulterated because it was used extralabelly without the supervision of a licensed veterinarian, violating 21 C.F.R. Part 530.11(a) and causing the drug to be unsafe and adulterated under Sections 512(a) and 501(a)(5) of the FD&C Act, respectively.

Rancho Cantera's December 5, 2012, response, which described steps to revise treatment protocols, was acknowledged.

Company
Rancho Cantera
Inspection Date
November 26, 2012
Product Type
Drugs
Office
Chicago District Office
People
  • Scott J. Macintire
  • William J. Croatt
Open in Dashboard

ID · 75ba5181-1ebd-4ccb-bbf5-a42608a4d935

Violation Codes9
21 U.S.C. 342(a)(2)(C)(ii)21 U.S.C. 342(a)(4)21 CFR 556.51021 CFR 530.3(a)21 U.S.C. 360b(a)(4)21 U.S.C. 360b(a)(5)21 CFR 530.11(a)21 U.S.C. 360b(a)21 U.S.C. 351(a)(5)

Full citation text and observation details available on the Dashboard.

KeyPedia
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.